Literature DB >> 1365552

Anticardiolipin antibodies in acute rheumatic fever.

F Figueroa1, X Berríos, M Gutiérrez, F Carrión, J P Goycolea, I Riedel, S Jacobelli.   

Abstract

Recent reports describe the association of antiphospholipid antibodies (aPL) with chorea or severe heart valve lesions in systemic lupus erythematosus, lupus-like disease, or the primary antiphospholipid antibody syndrome. We conducted a case series and a case-control investigation of patients with rheumatic fever with Sydenham chorea or other manifestations of rheumatic fever for anticardiolipin antibodies (aCL) during the acute attack and disease remission. Eighty percent of patients were positive for aCL during the rheumatic fever attack vs 40% when inactive (p = 0.035); IgG and IgM aCL increased significantly with disease activity. Individuals with or without Sydenham chorea were equally positive for aCL (76 and 83%, respectively). A significant association was found between IgM aCL and carditis: All patients with valvulitis had IgM aCL (100%) vs 37% of patients without valvular involvement (p = 0.02). aPL may play a role in the pathogenesis of some clinical manifestations of acute rheumatic fever.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365552

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Anti-endothelial cell antibodies in rheumatic heart disease.

Authors:  V Scalzi; H Abu Hadi; C Alessandri; C Croia; V Conti; L Agati; A Angelici; V Riccieri; C Meschini; A Al-Motarreb; A Al-Ansi; G Valesini
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.

Authors:  Simone Appenzeller; Steeven Yeh; Marcelo Maruyama; Solange Murta Barros; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

3.  Lack of antiphospolipid antibodies in long-term cardiac rheumatic fever.

Authors:  Jozélio Freire de Carvalho; Cláudia Goldenstein-Schainberg
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

4.  Rheumatic chorea and lupus anticoagulant.

Authors:  R de la Fuente Fernández
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

5.  Cholinergic supersensitivity of the iris in Alzheimer's disease.

Authors:  J Idiaquez; G Alvarez; R Villagra; R A San Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

6.  Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: long term follow up of patients with subclinical disease.

Authors:  F E Figueroa; M S Fernández; P Valdés; C Wilson; F Lanas; F Carrión; X Berríos; F Valdés
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 7.  Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant).

Authors:  Claudia Mendoza-Pinto; Mario García-Carrasco; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2018-08-20       Impact factor: 4.592

Review 8.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

Review 9.  Antiphospholipid antibodies in response to infection.

Authors:  Tadej Avcin; Natasa Toplak
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

10.  Rheumatic Fever.

Authors:  Ma Binotto; L Guilherme; Ac Tanaka
Journal:  Images Paediatr Cardiol       Date:  2002-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.